Qfitlia (fitusiran) is the first therapy for both hemophilia A or B, with or without inhibitors, available in the United ...

One particular application of AI on the rise at City of Hope is the development of a large language model (LLM) made ...

Republicans are aiming for major reductions in federal spending, and Medicaid seems a likely target. But the politics of ...

University of Pittsburgh Medical School researchers walk us through multiple approaches they’ve tried in the past, are currently using or plan to use in the future, as well as the significant ...

The CEOs of CVS Health and UnitedHealth Group praised pharmacy benefit managers and promised transparency during investor ...

The end of federal diversity, equity and inclusion programs in the federal government may have a ripple effect on social ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Lexeo Therapeutics’ gene therapy provides a healthy version of the frataxin gene, which is critical for energy production in ...

Current observations and foresight into the world of biosimilars, GLP-1s, PBM and payer trends, according to Jeff Casberg, MS ...

Researchers found that use of immunosuppressive medication was a strong protective factor, associated with a 60% reduction in ...

Eric Cannon, PharmD, FAMCP, discusses how precision medicine advancements and biomarker development can enable targeted ...

Panelists discuss how balancing survival benefits with quality of life involves careful monitoring of treatment-related adverse effects. Managing immune-related adverse events in patients on immune ...